🇺🇸 FDA
Patent

US 8748608

4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use

granted A61PA61P25/00A61P25/16

Quick answer

US patent 8748608 (4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P25/00, A61P25/16, A61P25/18, A61P25/30